What are the precautions for the drug preparation of Rozebalamin (methylcobalamin)?

When using Rozebalamin (methylcobalamin) to treat amyotrophic lateral sclerosis (ALS), the preparation process of the drug is very important, because improper preparation may affect the efficacy of the drug and may even cause safety hazards. The following are matters that require special attention during the pharmaceutical preparation of Rozebalamin:

1. Precautions when dissolving drugs

The preparation of Rozebalamin is in freeze-dried powder form and needs to be dissolved before use for injection. According to the drug instructions, when dissolving this product, it is necessary to use physiological saline specified in the Japanese Pharmacopoeia. This is important because other solutions may affect the stability or bioavailability of the drug. Therefore, it is necessary to strictly follow the instructions in the instructions and avoid using unapproved dissolving solutions.

Each bottle of Rozebalamin needs to be dissolved with 2.3ml of physiological saline. After dissolution, the required dose for injection is 2.0ml. Note that when using, the drug should be completely dissolved and no undissolved particles or suspended solids should appear. Do not use if medication is not completely dissolved. Drugs must be used as soon as possible after dissolving. Drugs that exceed 60 minutes should be discarded to avoid drug failure or bacterial contamination.

2. Operation to avoid light

Rozebalaminis extremely sensitive to light during drug preparation. If the medicine is exposed to strong light, it may cause the medicine to be less effective or the medicine ingredients to break down. Therefore, it must be strictly protected from light during preparation and use. Whether during the dissolution or injection stages of the drug, ensure that the drug is always shielded from light. This means that the drug should be injected immediately after it dissolves, and all containers and syringes should be protected from light exposure, especially within 60 minutes after the drug dissolves, after which unused liquid must be discarded.

3. Safe operation and selection of injection tools

When preparing drugs, all syringes and needles need to be kept sterile, except for the liquid in which the drug is dissolved. To reduce the risk of bacterial contamination, strict aseptic practices must be followed during use, including hand washing, wearing gloves, and using sterile utensils. In addition, syringe and needle selection should take into account the drug volume and the characteristics of the injection site. For Rozebalamin, a needle suitable for intramuscular injection must be used and avoid intravenous or subcutaneous injection. After each injection, used syringes and needles should be discarded immediately to avoid reuse.

4. Waste disposal after injection

RozebalaminThe disposal of waste generated during the preparation process and after use is also an important step. Waste liquid, used syringes and needles generated during the dissolution process must be disposed of according to the medical waste disposal requirements. Used syringes and needles should be discarded immediately into dedicated medical waste containers to avoid contamination or misuse by others. At the same time, medical staff should provide guidance on how to dispose of all equipment and liquid residues to ensure the safety and sterility of the operating environment.

5. Precautions during injection

After the drug is dissolved, the injection should be carried out strictly according to the dose. Extra caution is required during the injection process, especially for patients who self-inject at home. When injecting, you should choose a suitable intramuscular injection site, avoid repeatedly injecting the same site, and avoid injecting into nerve or blood vessel locations. When the injection needle is inserted, if the patient feels severe pain or sees blood flowing backward, he should immediately pull out the needle and inject again at another site. When handling the injection site, it is necessary to ensure that the area is kept clean and dry after each injection to prevent infection.

6. Monitoring and reaction after medication

Although Rozebalamin does not cause serious side effects in many patients, some patients may experience allergic reactions or discomfort at the injection site. Therefore, it is necessary to observe the patient's reaction in time after the drug is used, especially during the first injection. Medical personnel need to ensure that the patient is under observation within 30 minutes after the injection to ensure that no serious adverse reactions such as anaphylactic shock occur. If the patient feels unwell, measures should be taken immediately, such as stopping the medication and seeking medical treatment.

7. Handling of special situations

During the preparation and use of drugs, attention should be paid to the handling of some special situations. For example, if a patient forgets to take an injection, he or she needs to replenish it as soon as possible according to the actual situation, but the dose of each replenishment cannot exceed the prescribed amount. If you miss injections multiple times, you need to consult your doctor and rearrange your medication plan. For patients at different stages of treatment, doctors should adjust the drug use plan and monitoring plan according to the patient's actual condition to ensure maximum efficacy.

In summary, Rozebalamin requires special attention in every aspect of its preparation and use to ensure its safety and effectiveness in treatment. Correct dissolution operations, avoidance of drug exposure, strict compliance with aseptic operations and correct waste disposal measures are all key steps to ensure smooth treatment.

xa0

References:

[1]https://pins.japic.or.jp/pdf/newPINS/00071540.pdf

[2]https://www.eisai.com/news/2024/news202487.html